BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1825396)

  • 1. Nitric oxide but not prostacyclin has an autocrine function in porcine aortic endothelial cells.
    Schröder H; Machunsky C; Strobach H; Schrör K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():671-4. PubMed ID: 1825396
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. 1985.
    Gryglewski RJ; Moncada S; Palmer RM
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):494-503; discussion 491-3. PubMed ID: 9142426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of bradykinin, ionophore A23187 and trypsin on prostacyclin release from calf and pig aorta endothelial cells].
    Cheng J; Hong SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Oct; 14(5):351-6. PubMed ID: 1299538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cells synthesize nitric oxide from L-arginine.
    Palmer RM; Ashton DS; Moncada S
    Nature; 1988 Jun; 333(6174):664-6. PubMed ID: 3131684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
    Schini VB; Katusic ZS; Vanhoutte PM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):994-1000. PubMed ID: 2175809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells.
    Goulter AB; Avella M; Botham KM; Elliott J
    Clin Sci (Lond); 2003 Sep; 105(3):363-71. PubMed ID: 12757429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SKF 525A on the release of nitric oxide and prostacyclin from endothelial cells.
    Rees DD; Palmer RM; Moncada S
    Eur J Pharmacol; 1988 May; 150(1-2):149-54. PubMed ID: 3136027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of porcine coronary artery endothelial cells in culture: comparison with aortic endothelium.
    Ohbayashi A; Hiraga T; Okubo M; Murase T; Matsushita H; Hara M
    Biochem Biophys Res Commun; 1994 Jul; 202(1):504-11. PubMed ID: 8037755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae.
    Nishikawa T; Iwakiri N; Kaneko Y; Taguchi A; Fukushima K; Mori H; Morone N; Kadokawa J
    Biomacromolecules; 2009 Aug; 10(8):2074-85. PubMed ID: 19583242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide but not prostacyclin is an autocrine endothelial mediator.
    Schröder H; Strobach H; Schrör K
    Biochem Pharmacol; 1992 Feb; 43(3):533-7. PubMed ID: 1371684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase.
    Zellers TM; Wu YQ; McCormick J; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Feb; 21(2):131-8. PubMed ID: 11263259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurement of intracellular Ca(2+) and nitric oxide: a new method.
    Berkels R; Dachs C; Roesen R; Klaus W
    Cell Calcium; 2000 May; 27(5):281-6. PubMed ID: 10859594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyaspartoyl.L-arginine enhances prostacyclin synthesis in rat aortic endothelial cells.
    Tang Z; Yang J; Liu X; Wang Y; Peng S
    Eur J Pharmacol; 2008 Dec; 601(1-3):124-8. PubMed ID: 19026630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.
    Schuller-Petrovic S; Siedler S; Kern T; Meinhart J; Schmidt K; Brunner F
    Br J Pharmacol; 1997 Oct; 122(4):772-8. PubMed ID: 9375976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
    Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E
    Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular acidosis suppresses endothelial function by inhibiting store-operated Ca2+ entry via non-selective cation channels.
    Asai M; Takeuchi K; Saotome M; Urushida T; Katoh H; Satoh H; Hayashi H; Watanabe H
    Cardiovasc Res; 2009 Jul; 83(1):97-105. PubMed ID: 19351743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between nitric oxide and prostacyclin in myocardial ischemia and endothelial cell cultures.
    Schrör K; Woditsch I; Strobach H; Schröder H
    Basic Res Cardiol; 1991; 86 Suppl 2():117-25. PubMed ID: 1659372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-conductance K+ channel opener CGS7184 as a regulator of endothelial cell function.
    Wrzosek A; Łukasiak A; Gwóźdź P; Malińska D; Kozlovski VI; Szewczyk A; Chlopicki S; Dołowy K
    Eur J Pharmacol; 2009 Jan; 602(1):105-11. PubMed ID: 19028489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.